Prevalência de dislipidemia em adultos de meia-idade com polimorfismo do gene NOS3 e baixa aptidão cardiorrespiratória

Malagrino, Pamella A.; Sponton, Carlos H. G.; Esposti, Rodrigo D.; Franco-Penteado, Carla F.; Fernandes, Romulo A.; Bezerra, Marcos André C.; Albuquerque, Dulcinéia M.; Rodovalho, Cynara M.; Bacci, Maurício; Zanesco, Angelina.
Arq. bras. endocrinol. metab ; 57(1): 33-43, fev. 2013. ilus, graf, tab
Artículo en Portugués | LILACS | ID: lil-665760

Documentos relacionados

  1. [Prevalence of dyslipidemia in middle-aged adults with NOS3 gene polymorphism and low cardiorespiratory fitness].
  2. Statistically verified methods for determining predictors of development of arterial hypertension depending on endothelial nitric oxide synthase T786C gene promoter polymorphism using lipid profile indicators.
  3. Association of lipid-modifying therapy with risk of obstructive sleep apnea: A drug-target mendelian randomization study.
  4. Role of macrophage scavenger receptor 1 in the progression of dyslipidemia in acne vulgaris patients.
  5. Supplementation with Watermelon Extract Reduces Total Cholesterol and LDL Cholesterol in Adults with Dyslipidemia under the Influence of the MTHFR C677T Polymorphism.
  6. eNOS genotype modifies the effect of leisure-time physical activity on serum triglyceride levels in a Japanese population.
  7. The genetic counselor's role in management of patients with dyslipidemia.
  8. Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.
  9. [Controversies concerning screening and treatment of primary dyslipidemias in 2020].
  10. GALNT2 effect on HDL-cholesterol and triglycerides levels in humans: Evidence of pleiotropy?